Syntara Future Growth
Future criteria checks 0/6
Syntara's revenue is forecast to decline at 25.1% per annum while its annual earnings are expected to grow at 43.7% per year. EPS is expected to grow by 64.5% per annum.
Key information
43.7%
Earnings growth rate
64.5%
EPS growth rate
| Pharmaceuticals earnings growth | 21.2% |
| Revenue growth rate | -25.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 05 Aug 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2026 | 4 | -4 | -4 | -4 | 1 |
| 6/30/2025 | 4 | -13 | -10 | -10 | 1 |
| 6/30/2024 | 6 | -14 | -14 | -14 | N/A |
| 3/31/2024 | 19 | -10 | -15 | -15 | N/A |
| 12/31/2023 | 19 | -11 | -11 | -11 | N/A |
| 9/30/2023 | 12 | -18 | -16 | -16 | N/A |
| 6/30/2023 | 6 | -13 | -7 | -7 | N/A |
| 3/31/2023 | 18 | 2 | -7 | -7 | N/A |
| 12/31/2022 | 8 | -2 | -12 | -12 | N/A |
| 9/30/2022 | 18 | 2 | -11 | -11 | N/A |
| 6/30/2022 | 16 | -2 | -17 | -16 | N/A |
| 3/31/2022 | 14 | -16 | -12 | -12 | N/A |
| 12/31/2021 | 19 | -12 | -8 | -8 | N/A |
| 9/30/2021 | 28 | -1 | 5 | 5 | N/A |
| 6/30/2021 | 24 | -3 | 2 | 3 | N/A |
| 3/31/2021 | 27 | 5 | -2 | -1 | N/A |
| 12/31/2020 | 22 | -4 | -5 | -5 | N/A |
| 9/30/2020 | 12 | -13 | -11 | -11 | N/A |
| 6/30/2020 | 13 | -14 | -14 | -13 | N/A |
| 3/31/2020 | 13 | -21 | -13 | -12 | N/A |
| 12/31/2019 | 13 | -18 | -14 | -13 | N/A |
| 9/30/2019 | 13 | -18 | N/A | N/A | N/A |
| 6/30/2019 | 12 | -20 | -21 | -20 | N/A |
| 3/31/2019 | 7 | -27 | -20 | -19 | N/A |
| 12/31/2018 | 22 | -12 | -4 | -3 | N/A |
| 9/30/2018 | 21 | -22 | -13 | -12 | N/A |
| 6/30/2018 | 49 | 6 | 11 | 12 | N/A |
| 3/31/2018 | 51 | 10 | N/A | N/A | N/A |
| 12/31/2017 | 37 | -1 | N/A | -2 | N/A |
| 9/30/2017 | 36 | 7 | N/A | 9 | N/A |
| 6/30/2017 | 9 | -18 | N/A | -15 | N/A |
| 3/31/2017 | 8 | -16 | N/A | -13 | N/A |
| 12/31/2016 | 7 | -16 | N/A | -14 | N/A |
| 9/30/2016 | 8 | -14 | N/A | -15 | N/A |
| 6/30/2016 | 10 | -16 | N/A | -12 | N/A |
| 3/31/2016 | 47 | 16 | N/A | 21 | N/A |
| 12/31/2015 | 48 | 14 | N/A | 29 | N/A |
| 9/30/2015 | 49 | 21 | N/A | 27 | N/A |
| 6/30/2015 | 47 | 18 | N/A | 22 | N/A |
| 3/31/2015 | 5 | -34 | N/A | N/A | N/A |
| 12/31/2014 | 8 | -38 | N/A | -29 | N/A |
| 9/30/2014 | 5 | -51 | N/A | N/A | N/A |
| 6/30/2014 | 9 | -52 | N/A | -28 | N/A |
| 3/31/2014 | 5 | -44 | N/A | N/A | N/A |
| 12/31/2013 | 6 | -43 | N/A | -32 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UUDA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: UUDA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: UUDA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: UUDA's revenue is expected to decline over the next 3 years (-25.1% per year).
High Growth Revenue: UUDA's revenue is forecast to decline over the next 3 years (-25.1% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if UUDA's Return on Equity is forecast to be high in 3 years time